Search research articles
Contact Us
Filters
Showing results (121-130 of 157) with videos related to
Page
of 16
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 13, 2020
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Diana A Gorog, Susanna Price, Dirk Sibbing, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 21, 2024
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023
Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
Platelets
|
February 14, 2019
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome
William A E Parker, Rachel C Orme, Jessica Hanson, et al.
Diabetes/Metabolism Research and Reviews
|
November 1, 2019
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance
Francesca Santilli, Francesco Zaccardi, Rossella Liani, et al.
European Heart Journal
|
December 8, 2022
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis
Felicita Andreotti, Tobias Geisler, Jean-Philippe Collet, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 5, 2026
Cardiovascular pharmacotherapy in year in 2025
Juan Tamargo, Stefan Agewall, Giuseppe Ambrosio, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 9, 2025
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024
Juan Tamargo, Stefan Agewall, Giuseppe Ambrosio, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 5, 2024
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis
Bruna Gigante, Juan Tamargo, Stefan Agewall, et al.
American Journal of Hematology
|
November 25, 2003
MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation
Amos Toren, Galit Rozenfeld-Granot, Karen E Heath, et al.
Blood Advances
|
March 29, 2018
Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction
Oliver Borst, Patrick Münzer, Nada Alnaggar, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 157) with videos related to
Sort By:
Page
of 16
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 13, 2020
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Diana A Gorog, Susanna Price, Dirk Sibbing, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 21, 2024
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023
Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
Platelets
|
February 14, 2019
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome
William A E Parker, Rachel C Orme, Jessica Hanson, et al.
Diabetes/Metabolism Research and Reviews
|
November 1, 2019
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance
Francesca Santilli, Francesco Zaccardi, Rossella Liani, et al.
European Heart Journal
|
December 8, 2022
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis
Felicita Andreotti, Tobias Geisler, Jean-Philippe Collet, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 5, 2026
Cardiovascular pharmacotherapy in year in 2025
Juan Tamargo, Stefan Agewall, Giuseppe Ambrosio, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 9, 2025
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024
Juan Tamargo, Stefan Agewall, Giuseppe Ambrosio, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 5, 2024
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis
Bruna Gigante, Juan Tamargo, Stefan Agewall, et al.
American Journal of Hematology
|
November 25, 2003
MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation
Amos Toren, Galit Rozenfeld-Granot, Karen E Heath, et al.
Blood Advances
|
March 29, 2018
Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction
Oliver Borst, Patrick Münzer, Nada Alnaggar, et al.
Page
of 16